Cravatex Limited (CRAVATEX.BO)
INR 500.0
(-1.57%)
INR 500.0
(-1.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 209.8 Million | 1.43 Billion | -75.58 Million | -38.24 Million | 320.23 Million | -46.91 Million |
| Net Income | 48.27 Million | 583.33 Million | -185.43 Million | -297.52 Million | -24.25 Million | 168.83 Million |
| Depreciation & Amortization | 18.83 Million | 161.43 Million | 163.69 Million | 174.42 Million | 149.8 Million | 57.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 169.59 Million | 570.01 Million | -145.87 Million | -93.68 Million | 93.33 Million | -316.69 Million |
| Other non-cash items | -178.45 Million | 120.61 Million | 92.03 Million | 178.54 Million | 101.34 Million | 43.6 Million |
| Investing Cash Flow | -32.41 Million | 424.18 Million | 139.28 Million | 205.54 Million | -373.34 Million | 33.02 Million |
| Investments in PPE | -10.13 Million | 7.22 Million | -17.13 Million | -26.77 Million | -81.03 Million | -57.78 Million |
| Acquisitions | - | 381.51 Million | - | - | 364.57 Million | 143 Thousand |
| Investment purchases | -58.4 Million | -262 Thousand | - | - | -232.25 Million | -1.26 Million |
| Sales/Maturities of investments | 125 Thousand | 757 Thousand | 111.52 Million | 193.87 Million | 54 Thousand | 52.29 Million |
| Other Investing Activities | 35.99 Million | 34.95 Million | 44.89 Million | 38.44 Million | -424.68 Million | 39.64 Million |
| Financing Cash Flow | -3.87 Million | -1.67 Billion | -36.93 Million | -207.1 Million | 374.3 Million | -2.49 Million |
| Debt repayment | - | -1.47 Billion | -170.2 Million | -67.3 Million | -5.27 Million | -51.02 Million |
| Dividends payments | -3.87 Million | -7.75 Million | -7.75 Million | -2.58 Million | -11.91 Million | -2.58 Million |
| Common Stock Repurchased | - | - | - | -207.21 Million | 91.49 Million | - |
| Common Stock Issuance | - | - | - | 70 Million | 300 Million | - |
| Other Financing Activities | - | -189.64 Million | 141.02 Million | -2000.00 | -1000.00 | 51.11 Million |
| Accounts receivables | 122.47 Million | 977.62 Million | 31.92 Million | 201.24 Million | 136.88 Million | -492.34 Million |
| Accounts payables | -116.97 Million | -188.85 Million | 171.63 Million | -190.7 Million | 61.96 Million | -383.27 Million |
| Inventory | 183.72 Million | 653.01 Million | -93.39 Million | -33.9 Million | 125.24 Million | -474.37 Million |
| Other working capital | -19.62 Million | -871.77 Million | -256.04 Million | -70.32 Million | -230.75 Million | 1.03 Billion |
| Cash at beginning of period | 563.22 Million | 379.24 Million | 352.47 Million | 392.27 Million | 71.08 Million | 56.43 Million |
| Cash at end of period | 760.48 Million | 562.89 Million | 379.24 Million | 352.47 Million | 392.27 Million | 40.03 Million |
| Capital Expenditure | -10.13 Million | 7.22 Million | -17.13 Million | -26.77 Million | -81.03 Million | -57.78 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | 1000.00 | - |
| Net cash flow / Change in cash | 197.25 Million | 183.64 Million | 26.77 Million | -39.8 Million | 321.19 Million | -16.39 Million |
| Free Cash Flow | 199.66 Million | 1.44 Billion | -92.71 Million | -65.02 Million | 239.19 Million | -104.7 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.83 Million | 48.27 Million | 5.04 Million | 7.88 Million | 31.11 Million | 4.23 Million |
| Depreciation & Amortization | - | 18.83 Million | - | 4.88 Million | 5.28 Million | 4.73 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 169.59 Million | - | - | - | - |
| Other non-cash items | -4.83 Million | -178.45 Million | -5.04 Million | -7.88 Million | -31.11 Million | -4.23 Million |
| Investing Cash Flow | - | -32.41 Million | - | - | - | - |
| Investments in PPE | - | -10.13 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -58.4 Million | - | - | - | - |
| Sales/Maturities of investments | - | 125 Thousand | - | - | - | - |
| Other Investing Activities | - | 35.99 Million | - | - | - | - |
| Financing Cash Flow | - | -3.87 Million | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -3.87 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 122.47 Million | - | - | - | - |
| Accounts payables | - | -116.97 Million | - | - | - | - |
| Inventory | - | 183.72 Million | - | - | - | - |
| Other working capital | - | -19.62 Million | - | - | - | - |
| Cash at beginning of period | - | 563.22 Million | - | 603.59 Million | 572.48 Million | 563.22 Million |
| Cash at end of period | - | 760.48 Million | - | 613.37 Million | 603.59 Million | 4.23 Million |
| Capital Expenditure | - | -10.13 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 197.25 Million | - | 9.77 Million | 31.11 Million | -558.98 Million |
| Free Cash Flow | - | 199.66 Million | - | 9.77 Million | 31.11 Million | 4.23 Million |
JGCHEM
COLFF
600730
ALL-PI
002560
HANSUGAR